Ovation Diagnostics is a cancer diagnostics company committed to improving detection of ovarian cancer. Using a novel biomarker present in urine samples of ovarian cancer patients, we are developing a laboratory assay and a rapid lateral flow test which will offer women an efficient, noninvasive and affordable method of detecting ovarian cancer. Early and accurate detection is essential for success in treatment of ovarian cancer. Unfortunately the majority of existing tests lack the ability to accurately detect the cancer in its early stages which results in lower survival rate. We are utilizing a novel biomarker to develop a test that will demonstrate higher specificity and sensitivity for ovarian cancer compared to existing methods of detection. This novel diagnostic technology will have a significant impact by improving the survival rate of affected women.